Free Trial

VolitionRX (VNRX) SEC Filings & 10K Form

VolitionRX logo
$0.69 +0.03 (+5.12%)
As of 08/29/2025 04:10 PM Eastern

Recent VolitionRX SEC Filings

DateFilerForm TypeView
08/15/2025
4:16 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 10-Q/A
08/14/2025
8:43 PM
ARMISTICE CAPITAL, LLC (Filed by)
VolitionRX (Subject)
VOLITIONRX LTD (Subject)
Form SCHEDULE 13G/A
08/06/2025
8:00 AM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
8:00 AM
Innes Guy Archibald (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Forterre Gael (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Plummer Nicholas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
3:01 PM
Batchelor Ann-Louise (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:01 PM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:01 PM
Hughes Terig (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
11:15 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form EFFECT
07/03/2025
1:17 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form S-3
Registration statement under Securities Act of 1933  
07/03/2025
12:05 PM
Retter Andrew (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Butera Salvatore Thomas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Batchelor Ann-Louise (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Forterre Gael (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:05 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:06 PM
Plummer Nicholas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
7:27 AM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
6:55 AM
Innes Guy Archibald (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:05 PM
Hughes Terig (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Forterre Gael (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Butera Salvatore Thomas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Rootsaert Rodney Gerard (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Michel Gaetan (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Plummer Nicholas (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:06 PM
Nguyen Kim (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:07 PM
Kway Jasmine (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
12:23 PM
Micallef Jacob Vincent (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
11:43 AM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
4:26 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:27 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2025
2:20 PM
ARMISTICE CAPITAL, LLC (Filed by)
VolitionRX (Subject)
VOLITIONRX LTD (Subject)
Form SCHEDULE 13G/A
04/22/2025
4:14 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 424B5
04/22/2025
4:16 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2025
11:15 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form EFFECT
04/16/2025
3:24 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form RW
04/15/2025
11:15 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form EFFECT
04/14/2025
8:39 AM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form S-3/A
04/04/2025
4:20 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form S-1
Registration statement under Securities Act of 1933  
04/04/2025
4:22 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
“Sell Nvidia before earnings” (Ad)

Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel

See Eric’s full analysis and get all 7 free trade ideas here
03/27/2025
7:13 AM
Innes Guy Archibald (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
7:13 AM
Reynolds Cameron John (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:11 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2024
8:02 AM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 424B5
11/14/2024
3:24 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
3:23 PM
STILL TIMOTHY I (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/30/2024
3:38 PM
Rubin Ethel (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:21 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:29 PM
Rubin Ethel (Reporting)
VolitionRX (Issuer)
VOLITIONRX LTD (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2024
3:01 PM
VolitionRX (Filer)
VOLITIONRX LTD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NYSEAMERICAN:VNRX) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners